Stay updated on Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial

Sign up to get notified when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new final publication entry for Brown et al. (Bone Changes With Long-Acting Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention in Cisgender Men and Transgender Women: HPTN 083) is added to Publications, and the prior online-ahead-of-print listing is removed.
    Difference
    0.0%
    Check dated 2026-01-06T22:59:45.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Locations section updated to add new study sites across multiple US states and international locations (examples include Alabama, California, Buenos Aires, São Paulo, Bangkok, Western Cape, and more). The HHS Vulnerability Disclosure link was removed.
    Difference
    2%
    Check dated 2025-12-23T10:22:09.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Added a PubMed auto-fill notice for publications and updated the page revision to v3.3.2; removed the older PubMed note and the v3.2.0 revision label.
    Difference
    0.1%
    Check dated 2025-11-24T17:02:34.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the Study Details page for NCT02720094; the notice informed users that information may not be up to date due to funding lapses and directed readers to cc.nih.gov and opm.gov.
    Difference
    0.2%
    Check dated 2025-11-17T15:04:03.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The new screenshot shows cosmetic formatting changes to the Study Details page, with no changes to the study design, eligibility criteria, primary outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:32:31.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    No substantive changes detected in core content, pricing, stock, or time slot availability. The addition and deletion simply swap the label from “Last Update Posted” to “Last Update Posted (Estimated),” which does not alter meaning or important information.
    Difference
    0.0%
    Check dated 2025-10-19T16:56:03.000Z thumbnail image

Stay in the know with updates to Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.